DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 47 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,000 | -50.0% | 2,670 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +100.0% | 2,670 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | -78.9% | 2,670 | -62.0% | 0.00% | – |
| Q1 2016 | $38,000 | -54.2% | 7,020 | 0.0% | 0.00% | – |
| Q4 2015 | $83,000 | +6.4% | 7,020 | -26.1% | 0.00% | – |
| Q3 2015 | $78,000 | -38.6% | 9,501 | +4.3% | 0.00% | – |
| Q2 2015 | $127,000 | +86.8% | 9,107 | +223.9% | 0.00% | – |
| Q1 2015 | $68,000 | +61.9% | 2,812 | +10.7% | 0.00% | – |
| Q4 2014 | $42,000 | +133.3% | 2,541 | +76.0% | 0.00% | – |
| Q3 2014 | $18,000 | -97.6% | 1,444 | -95.6% | 0.00% | -100.0% |
| Q2 2014 | $747,000 | -69.5% | 33,110 | -61.8% | 0.00% | -50.0% |
| Q1 2014 | $2,450,000 | – | 86,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $89,888,000 | 13.40% |
| EcoR1 Capital, LLC | 3,627,597 | $79,916,000 | 7.20% |
| Aquilo Capital Management, LLC | 614,436 | $13,536,000 | 5.08% |
| RTW INVESTMENTS, LP | 5,874,229 | $129,409,000 | 4.88% |
| BRIDGER MANAGEMENT, LLC | 1,981,633 | $43,655,000 | 3.15% |
| ACUTA CAPITAL PARTNERS, LLC | 387,500 | $8,537,000 | 2.11% |
| Integral Health Asset Management, LLC | 200,000 | $4,406,000 | 1.72% |
| Burrage Capital Management LLC | 104,047 | $2,292,000 | 1.54% |
| Parkman Healthcare Partners LLC | 240,000 | $5,287,000 | 1.53% |
| EAM Global Investors LLC | 122,237 | $2,693,000 | 1.08% |